Otsuka Holdings Co., Ltd. Otsuka Group News RSS http://www.otsuka.com Otsuka Holdings Co., Ltd. Otsuka Group News RSS Mon, 29 Jun 2026 09:00:00 +0900 Mon, 29 Jun 2026 09:00:00 +0900 60 Joint Research with Tohoku University Establishment of a Collaborative Research Program on Water Turnover and Total Conditioning https://www.otsuka.co.jp/en/company/newsreleases/2026/20260629_1.html Mon, 29 Jun 2026 09:00:00 +0900 1597 Otsuka Announces Positive Phase 3b Results for Centanafadine in Adults with ADHD and Comorbid Anxiety https://www.otsuka.co.jp/en/company/newsreleases/2026/20260625_1.html Thu, 25 Jun 2026 09:00:00 +0900 1596 Taiho Pharmaceutical Earns First Silver Medal in EcoVadis Sustainability Rating https://www.taiho.co.jp/en/release/2026/20260625.html Thu, 25 Jun 2026 09:00:00 +0900 1595 Otsuka America Establishes the POCARI SWEAT SCIENCE ADVISORY BOARD Announces New Heat Illness Prevention Guidance to Address Heat Challenges in the United States https://www.otsuka.co.jp/en/company/newsreleases/2026/20260624_1.html Wed, 24 Jun 2026 09:00:00 +0900 1594 Otsuka Pharmaceutical Completes Acquisition of Transcend Therapeutics https://www.otsuka.co.jp/en/company/newsreleases/2026/20260615_1.html Mon, 15 Jun 2026 09:00:00 +0900 1593 Otsuka Foods’ Biwako Research Institute Develops “Oishisa LENS,” an AI System That Predicts Flavor Profiles and Recipes to Secure Expertise Transfer and Enhance Product Design 58 Years After the Brand’s Launch, Preserving Bon Curry’s Signature Taste for the Next Generation https://www.otsukafoods.co.jp/en/news/20260611.html Thu, 11 Jun 2026 09:00:00 +0900 1592 Otsuka Establishes “Heatstroke Countermeasure Industry-Government-Academia Consortium” with the National Institute for Environmental Studies and Other Partners https://www.otsuka.co.jp/en/company/newsreleases/2026/20260605_1.html Fri, 05 Jun 2026 09:00:00 +0900 1590 Otsuka Presents Positive Interim Phase 3 VISIONARY eGFR Data Showing VOYXACT (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN) https://www.otsuka.co.jp/en/company/newsreleases/2026/20260605_2.html Fri, 05 Jun 2026 09:00:00 +0900 1591 Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting https://www.otsuka.co.jp/en/company/newsreleases/2026/20260529_1.html Fri, 29 May 2026 09:00:00 +0900 1589 Otsuka Launches New Program FACEDUO “Heat Illness Prevention VR” Enabling Early Awareness and Action Through Simulated Experiences to Help Prevent the Onset and Severity of Heat Illness in Older Adults https://www.otsuka.co.jp/en/company/newsreleases/2026/20260518_1.html Mon, 18 May 2026 09:00:00 +0900 1588